Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens

Clinical trial NCT02635984 · COMPLETED

Trial details

NCT number: NCT02635984
Sponsor: Augusta University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Complications of Bone Marrow Transplant Hematologic Neoplasms

Start date: 2015-11-01
Primary completion: 2017-12-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.